Generics News

Generics News

Lupin Launches Generic Glumetza HCI ER Tabs

Lupin announced the launch of Metformin HCl ER Tablets, the generic version of Santarus' Glumetza HCl ER Tablets.

Generic Vytorin Gets Tentative FDA Approval

Impax announced that the Food and Drug Administration (FDA) has granted tentative approval for its Abbreviated New Drug Application (ANDA) for Ezetimibe and Simvastatin Tablets, the generic version of Merck's Vytorin.

Teva Launches Generic Integrilin Injection

Teva announced the launch of Eptifibatide Injection, the generic version of Merck's Integrilin.

Mylan Launches Generic Felbatol

Mylan announced the launch of Felbamate Tablets, the generic version of Meda's Felbatol.

Lupin Approved for Potassium Chloride Extended Release Caps

Lupin announced that it has received final approval from the Food and Drug Administration (FDA) for its Potassium Chloride Extended Release Capsules, a generic version of Actavis' Potassium Chloride Extended Release Capsules.

ANI Launches Nimodipine 30mg Caps

ANI Pharmaceuticals and Sofgen announced the launch of their Nimodipine Capsules.

Mylan Launches Generic Ortho Tri-Cyclen Lo

Mylan announced the launch of Norgestimate and Ethinyl Estradiol Tablets, 0.18mg/0.025mg, 0.215mg/0.025mg, and 0.25mg/0.025mg, the generic version of Janssen's Ortho Tri-Cyclen Lo tablets.

Lupin Approved for Generic Femhrt Tabs

Lupin announced that it has received final approval from the Food and Drug Administration (FDA) for Fyavolv (norethindrone acetate and ethinyl estradiol) Tablets, the generic version of Warner Chilcott's Femhrt Tablets.

Teva Launches Generic Birth Control Tablets

Teva has announced the launch of Tri-Lo-Sprintec (norgetimate and ethinyl estradiol) tablets, the generic version of Janssen's Ortho Tri-Cyclen Lo.

Mylan Launches Generic Zyvox Tabs

Mylan announced the launch of Linezolid Tablets, the generic version of Pfizer's Zyvox Tablets.